The nurse anticipates that a client admitted with acute ...

[kwoodring]

The nurse anticipates that a client admitted with acute pancreatitis will be treated with which medications?
 
  Standard Text: Select all that apply.
  1. Hydromorphone (Dilaudid)
  2. Cimetidine (Tagamet)
  3. Acetazolamide (Diamox)
  4. Dicyclomine (Bentyl)
  5. Pancrelipase (Creon)

Question 2

Which statement is true regarding the use of pancreatic enzyme replacement in the pharmacotherapy of pancreatitis?
 
  1. Its use is contraindicated when the client has cystic fibrosis.
  2. Its use is indicated when lack of pancreatic enzyme secretion causes malabsorption disorders.
  3. Its use is contraindicated when the client has pain in the abdomen.
  4. Its use is indicated when the client has acute pancreatitis.

[nanny]

Answer to Question 1

Correct Answer: 1,2,3,4
Rationale 1: For clients with acute pain, an opioid such as hydromorphone (Dilaudid) brings effective relief.
Rationale 2: To reduce gastric and pancreatic juice secretions, H2-receptor blockers such as cimetidine (Tagamet) may be prescribed.
Rationale 3: To decrease the amount of pancreatic enzymes secreted, carbonic anhydrase inhibitors such as acetazolamide (Diamox) may be used.
Rationale 4: To decrease the amount of pancreatic enzymes secreted, antispasmodics such as dicyclomine (Bentyl) may be used.
Rationale 5: Pancreatic enzyme supplementation is often used in clients with chronic pancreatitis.
Global Rationale: For clients with acute pain, an opioid such as hydromorphone (Dilaudid) brings effective relief. To reduce gastric and pancreatic juice secretions, H2-receptor blockers such as cimetidine (Tagamet) may be prescribed. To decrease the amount of pancreatic enzymes secreted, carbonic anhydrase inhibitors such as acetazolamide (Diamox) may be used. To decrease the amount of pancreatic enzymes secreted, antispasmodics such as dicyclomine (Bentyl) may be used. Pancreatic enzyme supplementation is often used in clients with chronic pancreatitis, not acute pancreatitis

Answer to Question 2

Correct Answer: 2
Rationale 1: Its use is indicated when the client has cystic fibrosis.
Rationale 2: Its use is indicated when lack of pancreatic enzyme secretion causes malabsorption disorders, as it helps to digest fats and prevent steatorrhea.
Rationale 3: It can relieve pain in the abdomen that is caused by chronic pancreatitis.
Rationale 4: Its use is indicated when the client has chronic pancreatitis.
Global Rationale: Its use is indicated when lack of pancreatic enzyme secretion causes malabsorption disorders, as it helps to digest fats and prevent steatorrhea. Cystic fibrosis and chronic pancreatitis may both require treatment with these drugs. Pain in the abdomen is a finding associated with both these disorders.

[kwoodring]

Thank you!

[nanny]

Always glad to help...